Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage
Top Cited Papers
- 18 June 2014
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 311 (23) , 2414-2421
- https://doi.org/10.1001/jama.2014.5990
Abstract
Research from JAMA — Thrombolysis for Pulmonary Embolism and Risk of All-Cause Mortality, Major Bleeding, and Intracranial Hemorrhage — A Meta-analysisKeywords
This publication has 38 references indexed in Scilit:
- Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary EmbolismNew England Journal of Medicine, 2012
- Thrombolytic Therapy in Unstable Patients with Acute Pulmonary Embolism: Saves Lives but UnderusedThe American Journal of Medicine, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- Sequential methods for random‐effects meta‐analysisStatistics in Medicine, 2010
- Estimating required information size by quantifying diversity in random-effects model meta-analysesBMC Medical Research Methodology, 2009
- Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE RegistryThrombosis and Haemostasis, 2008
- Death and Disability from Warfarin-Associated Intracranial and Extracranial HemorrhagesThe American Journal of Medicine, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985
- A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary EmbolismActa Medica Scandinavica, 1978